Associate Professor of Maternal Health Clinical Trials, Tommy's National Centre for Miscarriage Research & WHO Collaborating Centre, University of Birmingham.
Birmingham, England
Joined June 2011
- Tweets138
- Following76
- Followers218
- Likes49
Adam Devall retweeted
This important preliminary finding that first trimester vaginal micronized progesterone might reduce pre-eclampsia needs exploring in a large, multi-centre clinical trial targeting women at risk of pre-eclampsia.
The latest study from our National Centre for Miscarriage Research has found giving progesterone in early pregnancy could reduce the risk of pre-eclampsia.
Read more: bit.ly/3MAaZhV
#EarlyPregnancy
Huge congratulations to @arricoomarasamy on this fantastic achievement. This accolade could not be more deserved.
Delighted to see Prof @arricoomarasamy awarded an OBE in the King’s Birthday Honours.
Prof Coomarasamy received his undergraduate medical education here at Birmingham & has been recognised for research into miscarriage & severe bleeding in childbirth
birmingham.ac.uk/news/2023/l…
ALT Prof Arri Coomarasamy sat at a desk with a laptop in front of him and bookshelves behind
Adam Devall retweeted
ICYMI: The vital findings from the @EmotiveTrial have been published.
It's a major breakthrough, fronted by @arricoomarasamy and @adam_devall.
Read the @NEJM paper: nejm.org/doi/full/10.1056/NE…
A 🆕 trial promises a major breakthrough in preventing deaths from postpartum bleeding, which is the leading cause of maternal mortality globally.
Following the intervention, severe bleeding after childbirth was reduced by more than 60%
👉 bit.ly/42wFP08
Simple intervention for severe blood loss after childbirth is found to save lives @EmotiveTrial #PPH bmj.com/content/381/bmj.p105…
Adam Devall retweeted
We’re incredibly thankful to @gatesfoundation and @WHO for enabling research @unibirmingham led by @arricoomarasamy and @adam_devall that reduces deaths from heavy bleeding during childbirth by 60%.
Find out more: birmingham.ac.uk/news/2023/l…
I’m very encouraged by the E-MOTIVE Trial results released today at #IMNHC2023 to treat postpartum hemorrhage, the #1 cause of maternal mortality. This new approach led by @unibirmingham and @WHO could drastically improve women’s chances of surviving childbirth globally. b-gat.es/3BclMsw
Adam Devall retweeted
Incredibly proud to be a part of this vital work from our researchers @arricoomarasamy and @adam_devall who have reported the findings in @NEJM this week
I’m very encouraged by the E-MOTIVE Trial results released today at #IMNHC2023 to treat postpartum hemorrhage, the #1 cause of maternal mortality. This new approach led by @unibirmingham and @WHO could drastically improve women’s chances of surviving childbirth globally. b-gat.es/3BclMsw
Adam Devall retweeted
Today, we’re pleased to launch our new 10-year strategy. It’s inclusive, designed to be courageous & defines who we are as an organisation.
Together, we can stop the heartbreak and devastation of baby loss and make pregnancy and birth safe – for everyone: bit.ly/3prunF6
Adam Devall retweeted
Good news: a new trial to manage postpartum bleeding shows highly promising results. This could represent a major breakthrough in reducing maternal deaths. #HealthForAll
xitter.cf/WHO/status/16558646562…
A 🆕 trial promises a major breakthrough in preventing deaths from postpartum bleeding, which is the leading cause of maternal mortality globally.
Following the intervention, severe bleeding after childbirth was reduced by more than 60%
👉 bit.ly/42wFP08
Adam Devall retweeted
I’m very encouraged by the E-MOTIVE Trial results released today at #IMNHC2023 to treat postpartum hemorrhage, the #1 cause of maternal mortality. This new approach led by @unibirmingham and @WHO could drastically improve women’s chances of surviving childbirth globally. b-gat.es/3BclMsw
Adam Devall retweeted
A milestone moment for ending #PPH.
Honoured to co-moderate #IMNHC2023 panel with HE Dr Jallah -MOH-#Liberia on the release of results of the multi-country randomised E-MOTIVE trial -trial shows 60% reduction by early detection & first response treatment bundle for PPH
@alignmnh
It has been a tremendous effort by everyone involved to get the results of the @EmotiveTrial published so quickly, and the findings presented today at the #IMNHC2023 conference
⚡️Breaking news: results from @EmotiveTrial presented for the 1st time @ #IMNHC2023
PPH is leading cause of maternal health 🌍
We found a 60% reduction in composite outcome: severe PPH, laparotomy for bleeding or death from bleeding
Read more in @nejm bit.ly/42AGEFf
Adam Devall retweeted
The package of interventions or E-MOTIVE, incl.:
💟 Detect Early
💟 Uterine Massage
💟 Treat with Oxytocic medicines and Tranexamic acid to contract the womb & stop the bleeding
💟 Give IntraVenous fluid (IV fluid)
💟 Examine and when needed, escalate to advanced care
Adam Devall retweeted
In a large, cluster-randomized trial involving patients with PPH after vaginal delivery, a multicomponent intervention lowered the risk of severe PPH, laparotomy for bleeding, or maternal death from bleeding. Full results of the E-MOTIVE trial: nej.md/3O6GTEn
#IMNHC2023
Postpartum haemorrhage affects ~24 million women per year and is the leading cause of #maternalmortality worldwide. This study finds that the condition can be identified and treated quicker by using a low-cost drape to measure blood loss and bundling @WHO recommended treatments.
A 🆕 trial promises a major breakthrough in preventing deaths from postpartum bleeding, which is the leading cause of maternal mortality globally.
Following the intervention, severe bleeding after childbirth was reduced by more than 60%
👉 bit.ly/42wFP08
The large trial involved more than 200,000 women around the world, with 80 hospitals taking part across Kenya, Nigeria, South Africa and Tanzania. It was supported by @gatesfoundation and led by @WHOCCGWH. Read the paper: nejm.org/doi/full/10.1056/NE…
Adam Devall retweeted
@EmotiveTrial featured on @LBCNews this morning! Listen to interview with @adam_devall at 11:30am BST globalplayer.com/live/lbcnew… @unibirmingham @unibirm_MDS @IMSR_UoB @UoB_IAHR @WHOCCGWH @bIGIdeas_UoB @birminghamalum @BhamCTU @ammalife @theAliceRoberts
It's the day before the PPH evidence and consensus meeting with @thelancet! We're so pleased to be welcoming leading experts to @Birminghamdubai to share the latest knowledge on #maternalhealth & #PPH. See you all bright and early! @bIGIdeas_UoB @WHOCCGWH @IMSR_UoB
It was a great honour to receive this @unibirmingham impact award for policy change from @ProfWiddows and @theAliceRoberts for our group's work on progesterone treatment to prevent miscarriage
I'm so sorry that COVID meant I couldn't be there, but I can't wait to meet you in person at the next opportunity @kathabrahams @tommys 😊
Wonderful day @tommysbham with @arricoomarasamy and his amazing colleagues hearing about the groundbreaking research they’re doing to reduce the number of miscarriages and save more babies’ lives. Another dose of inspiration as I settle in @tommys 😊
Important new research on #miscarriage prevention with the largest ever trial on the subject in women with threatened pregnancy loss
We are delighted to share the findings of the @PRISM_trial. The results show that progesterone treatment can prevent #miscarriage in women with early pregnancy bleeding and a history of one or more previous pregnancy losses @Tommys_baby @BhamCTU @IMSR_UoB